Alfred NijkerkCEO

Alfred holds a MSc in Pharmacy and a PharmD from Utrecht University. Starting as an Industrial Pharmacist, he founded two pharmaceutical contract manufacturing companies before founding VenGen, a hands-on investors and life sciences start-up management company, in 2001. Since then, with VenGen, he co-founded several life science ventures, amongst which UbiQ, SumiQ, FlexGen, Diagnoptics, Photonics Healthcare, ViciniVax and to-BBB. Alfred has been CBO of to-BBB and CEO of ViciniVax. Currently, Alfred holds the position of CEO of UbiQ and the joint-venture company SumiQ.